Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Scientific Reports|February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trialJochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
Nature Communications|July 26, 2016
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxiaThomas M Ashton, Emmanouil Fokas, Leoni A Kunz-Schughart, et al.
Clinical and Translational Radiation Oncology|March 5, 2026
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancerGiuditta Chiloiro, Angela Romano, Regina Beets-Tan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2016
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerJames M Wilson, Emmanouil Fokas, Susan J Dutton, et al.
Mayo Clinic Proceedings|February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled TrialsDario Pasalic, C David Fuller, Walker Mainwaring, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centeredKrishan R Jethwa, J Joshua Smith, Hanna Sanoff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trialsKelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant GliomaMartin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation OncologySimone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Scientific Reports|February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trialJochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
Nature Communications|July 26, 2016
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxiaThomas M Ashton, Emmanouil Fokas, Leoni A Kunz-Schughart, et al.
Clinical and Translational Radiation Oncology|March 5, 2026
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancerGiuditta Chiloiro, Angela Romano, Regina Beets-Tan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2016
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerJames M Wilson, Emmanouil Fokas, Susan J Dutton, et al.
Mayo Clinic Proceedings|February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled TrialsDario Pasalic, C David Fuller, Walker Mainwaring, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centeredKrishan R Jethwa, J Joshua Smith, Hanna Sanoff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trialsKelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant GliomaMartin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation OncologySimone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
Pageof 16